<p>This is a $149,998.88 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to De Novo DNA, a self-certified small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for "HIGHLY SCALABLE MULTIPLEXED CRISPR APPLICATIONS USING ADVANCED PART TOOLBOXES AND CIRCUITS" and has an ultimate completion date of October 7, 2018. The contract is designated as a Total Small Business set-aside.</p>
This is a Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Etaphase, Incorporated, a small business, as part of the Small Business Innovation Research (SBIR) Phase II program. The contract has a firm fixed price of $1,500,000.00 and a period of performance ending on March 31, 2025. The contract was set aside for small businesses. No additional information about the specific products or services being delivered under this SBIR Phase II contract was...
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
<p>This is a $1,684,705.00 Firm Fixed Price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to American Semiconductor, Inc., a small business manufacturer, under the SBIR Program Phase II. The contract is for the development and characterization of an ultra-thin conformal electronic system, with a period of performance ending on January 11, 2027. The contract was set aside for small businesses.</p>
This is a $3,007,557.97 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Therapeutics Inc., a small business biotechnology company. The contract is for the development of new platform technologies for viral and therapeutic evolution assays under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract has a firm fixed price pricing type and a period of performance through November 2022. Autonomous Therapeutics has also...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Tiny Farms Inc., a for-profit organization, for a project titled "Screening Random Mutagenesis for Genetic Trait Mapping in Gryllodes sigillatus." The contract has a firm fixed price of $141,650.95 and a completion date of January 19, 2018. The contract is a definitive contract, which means it is a complete and final agreement between the parties. The...
This is a $1,496,660.82 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Echelon Biosciences Inc., a small business manufacturer of goods, for the development of Transgenic Black Soldier Flies for Sustainable, Improved Nutrition under the SBIR 16.3 Phase II program. The contract has a period of performance ending on October 4, 2021 and was set aside for total small business participation. Echelon Biosciences Inc. is a subsidiary of Frontier...
<p>This is a fixed-price, SBIR Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Synapticad Sales, Inc., a self-certified small disadvantaged business that manufactures goods. The contract has a potential value of $153,209.88 and a completion date of April 30, 2018. It was set aside for small businesses. The contract is for research under DARPA's SBIR (Small Business Innovation Research) program.</p>
Zymergen Inc. was awarded a $24.8 million other transaction agreement by the Defense Advanced Research Projects Agency to deliver on Task Area 2 of the LIVING FOUNDRIES: 1000 MOLECULES program. Under this effort, the Oakland, California-based company will leverage its synthetic biology capabilities to produce any microbe capable of manufacturing any target molecule. No set-aside designation was applied to this award. DARPA's LIVING FOUNDRIES initiative aims to develop a robust, scalable, and...
This is a $749,986 firm-fixed-price federal contract awarded to Design-Zyme LLC, a small biotechnology company, by the Defense Advanced Research Projects Agency (DARPA). The contract is for a study on "Enhanced Enzymes for Long-Term Continuous Monitoring Applications" under DARPA's Biological Technologies Office (BTO). The contract has a completion date of December 31, 2017 and does not utilize a set-aside. Based on Design-Zyme LLC's background, the contract likely involves the...